Advancements in Digital Modeling: Creating Virtual Cell Laboratories for Future Research

Researchers have developed a new computer program that mimics cellular behavior across the body, paving the way for virtual cell laboratories to test drugs and study biological processes more efficiently.
Scientists from leading institutions such as Johns Hopkins University, Indiana University, the University of Maryland School of Medicine, and Oregon Health & Science University are making significant progress toward developing a sophisticated computer program that emulates cellular behavior across different parts of the human body. This innovative software builds upon mathematical analyses of how human and animal cells behave, aiming to simulate these processes virtually before conducting expensive laboratory experiments with live cells.
The project, initiated at a workshop focused on the foundational software 'PhysiCell,' is based on the concept of agents—mathematical entities that mimic cell actions governed by DNA and RNA instructions. Each cell type is represented by an agent that can interact with others and environmental factors such as therapeutics and oxygen, allowing researchers to visualize complex biological interactions including tumor growth, brain cell organization, and tissue formation.
This model serves as a potential 'digital twin,' enabling researchers to test drug effects on cancer cells, investigate gene-environment interactions during brain development, and explore cellular processes in scenarios where real-world studies are challenging. For example, initial models based on pancreatic tumors and laboratory experiments with breast cancer cells have successfully simulated tumor invasion and growth, validating the software’s accuracy.
One of the notable features is the use of human-readable grammar—similar to an Excel spreadsheet—that simplifies creating and modifying models without extensive programming knowledge. This democratization of modeling technology means that scientists can quickly develop complex simulations, making large-scale biological modeling more accessible.
The collaboration also explores advancing models of brain development and cancer by integrating high-resolution data from sources like the Allen Brain Atlas. Upcoming efforts include refining the software to simulate how cells form neural circuits and respond to various stimuli, pushing toward more comprehensive and precise virtual representations of biology.
Overall, this breakthrough in digital modeling aims to revolutionize biomedical research by reducing the need for costly experiments, prioritizing promising hypotheses, and ultimately accelerating discoveries in disease understanding and treatment development.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Resurgence of a Forgotten Opioid as a Deadly Street Drug
Nitazenes, highly potent synthetic opioids, have resurfaced as a major and often unseen threat in the overdose crisis due to their extreme potency and detection challenges. Experts emphasize the need for increased awareness, testing, and harm reduction strategies to combat this emerging public health emergency.
Lower Hospitalization Rates Among Migrants in Austria Compared to Native Citizens
A study reveals lower hospitalization rates among migrants in Austria compared to native citizens, with higher readmission rates indicating potential access barriers. Enhanced healthcare strategies are essential for equitable access.
Understanding How Cellular Senescence Contributes to Disease Development
Explore how cellular senescence influences aging and disease progression, with ongoing research highlighting potential therapeutic targets for age-related conditions.
New Insights into How Immune Cells Can Undermine Cancer Treatments
Innovative research reveals how immune cells produce FAS-L, causing self-destruction that hampers cancer immunotherapy efforts. New strategies aim to enhance treatment effectiveness.